Clinical Trial Update: NeoAdjuvant Pembrolizumab and STEreotactic Radiotherapy Prior to Nephrectomy for Renal Cell Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial investigating neoadjuvant pembrolizumab with stereotactic radiotherapy before nephrectomy in renal cell carcinoma; currently recruiting at Peter M…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Renal Cell Carcinoma

Drugs mentioned

• KEYTRUDA (PEMBROLIZUMAB)

Snippet

Sponsor: Peter MacCallum Cancer Centre, Australia | Conditions: Renal Cell Carcinoma, Clear Cell, Somatic | Phase 2 | Status: RECRUITING